142 related articles for article (PubMed ID: 3611297)
1. Total hemolytic complement (CH50) and its fractions (C3 and C4) in the sera of patients with carcinoma of the oral cavity, uterine cervix, and breast.
Vijayakumar T; Ankathil R; Remani P; Beevi VM; Vijayan KK; Panicker CK
J Clin Immunol; 1987 Jul; 7(4):300-3. PubMed ID: 3611297
[TBL] [Abstract][Full Text] [Related]
2. Total hemolytic complement (CH50) and its fractions (C3 and C4) in the sera of patients with premalignant and malignant lesions of the oral cavity.
Rajendran R; Remani P; Vijayakumar T; Vasudevan DM
Ann Dent; 1990; 49(1):36-8, 51. PubMed ID: 2346298
[TBL] [Abstract][Full Text] [Related]
3. Total hemolytic complement (CH50) and its fractions C3 and C4 in the sera of patients with localized juvenile periodontitis.
Anil S; Beena VT; Remani P; Mysore J; Vijayakumar T
Ann Dent; 1993; 52(1):18-20. PubMed ID: 8323245
[TBL] [Abstract][Full Text] [Related]
4. Serum immunoglobulins in patients with carcinoma of the oral cavity, uterine cervix and breast.
Vijayakumar T; Ankathil R; Remani P; Sasidharan VK; Vijayan KK; Vasudevan DM
Cancer Immunol Immunother; 1986; 22(1):76-9. PubMed ID: 3708632
[TBL] [Abstract][Full Text] [Related]
5. Immunology of chronic generalized periodontitis. 2. Estimation of total hemolytic complement (CH 50) and its fractions C3 and C4.
Anil S; Beena VT; Remani P; Haseenabeevi M; Vijayakumar T
Indian J Dent Res; 1991; 2(3-4):35-9. PubMed ID: 1821159
[TBL] [Abstract][Full Text] [Related]
6. Total hemolytic complement (CH50) and its fractions (C3 and C4) in the sera of diabetic patients with periodontitis.
Anil S; Remani P; Vijayakumar T; Joseph PA
J Periodontol; 1990 Jan; 61(1):27-9. PubMed ID: 2107297
[TBL] [Abstract][Full Text] [Related]
7. Complement and its fractions (C3-C4) pattern in subjects with neoplasia.
Mangano A; Messina L; Birgillito S; Stivala F; Bernardini A
J Immunopharmacol; 1984; 6(3):147-62. PubMed ID: 6491311
[TBL] [Abstract][Full Text] [Related]
8. High affinity rosette forming cells in carcinoma of the oral cavity, uterine cervix and breast.
Vijayakumar T; Vasudevan DM
Cancer Lett; 1985 Jul; 27(3):339-45. PubMed ID: 4016728
[TBL] [Abstract][Full Text] [Related]
9. The difference between serum and plasma complement activity in primary renal disease.
Akagaki Y; Fujiwara Y; Nakanishi I; Orita Y; Ando A; Abe H; Kitamura H; Nagaki K; Inai S
Clin Nephrol; 1980 Aug; 14(2):75-80. PubMed ID: 7408259
[TBL] [Abstract][Full Text] [Related]
10. Serum complement levels in patients with cancer of the uterine cervix before and after radiation therapy.
Pulay AT; Füst G; Csömör A
Neoplasma; 1980; 27(2):211-6. PubMed ID: 7393359
[TBL] [Abstract][Full Text] [Related]
11. Changes in plasma levels of complement in patients with acute ischemic stroke.
Cojocaru IM; Cojocaru M; Tănăsescu R; Burcin C; Atanasiu AN; Petrescu AM; Mitu AC; Iliescu I; Dumitrescu L
Rom J Intern Med; 2008; 46(1):77-80. PubMed ID: 19157274
[TBL] [Abstract][Full Text] [Related]
12. [CH50, C3 and C4 in the serum and synovial fluid of rheumatoid arthritis patients].
Sheĭtanov I; Nikolov K; Petrova P
Vutr Boles; 1987; 26(4):66-70. PubMed ID: 3499707
[TBL] [Abstract][Full Text] [Related]
13. Level of complement activity and components C1, C4, C2, and C3 in complement response to bacterial challenge in malnourished rats.
Sakamoto M; Ishii S; Nishioka K; Shimada K
Infect Immun; 1981 May; 32(2):553-6. PubMed ID: 7251136
[TBL] [Abstract][Full Text] [Related]
14. An investigation into the relationships between serum levels of C3, C4 and CH50.
Salkie ML; Kelker DH
Vox Sang; 1981; 41(5-6):282-6. PubMed ID: 6976657
[TBL] [Abstract][Full Text] [Related]
15. Complement cleavage products in the phototoxic reaction of porphyria cutanea tarda.
Pigatto PD; Polenghi MM; Altomare GF; Giacchetti A; Cirillo R; Finzi AF
Br J Dermatol; 1986 May; 114(5):567-73. PubMed ID: 3487340
[TBL] [Abstract][Full Text] [Related]
16. Complement system and rheumatoid arthritis: relationships with autoantibodies, serological, clinical features, and anti-TNF treatment.
Di Muzio G; Perricone C; Ballanti E; Kroegler B; Greco E; Novelli L; Conigliaro P; Cipriani P; Giacomelli R; Perricone R
Int J Immunopathol Pharmacol; 2011; 24(2):357-66. PubMed ID: 21658310
[TBL] [Abstract][Full Text] [Related]
17. The complement system in the acute phase of myocardial infarction.
Yasuda M; Kawarabayashi T; Akioka K; Teragaki M; Oku H; Kanayama Y; Takeuchi K; Takeda T; Kawase Y; Ikuno Y
Jpn Circ J; 1989 Sep; 53(9):1017-22. PubMed ID: 2513427
[TBL] [Abstract][Full Text] [Related]
18. [Non-specific changes in the complement system in neoplastic processes].
Tiagotin IuV; Rybakova LP; Golota GZ; Ishchenko AM
Vopr Onkol; 2002; 48(2):206-10. PubMed ID: 12227070
[TBL] [Abstract][Full Text] [Related]
19. Monitoring the level of complement components during autologous blood stem cell transplantation in patients with malignant lymphomas.
Banyai A; Varga L; Barta A; Gopcsa L; Paloczi K
Cancer Immunol Immunother; 2004 Sep; 53(9):835-9. PubMed ID: 15052374
[TBL] [Abstract][Full Text] [Related]
20. Complement changes in falciparum malaria infection.
Phanuphak P; Hanvanich M; Sakulramrung R; Moollaor P; Sitprija V; Phanthumkosol D
Clin Exp Immunol; 1985 Mar; 59(3):571-6. PubMed ID: 3886219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
